Quantitative pharmacology modelling position available at LEO Pharma A/S, Denmark

From: Stine Timmermann Ottesen Date: April 25, 2018 job Source: cognigen.com
We are pleased to announce an open modelling position at the department of Clinical Pharmacology, LEO Pharma, Denmark. Population Pharmacokineticist to Clinical Pharmacology Can you take on the role as LEOs new specialist in quantitative pharmacology? If you have a solid background within population pharmacokinetics you now have the opportunity to take on the challenge and become LEO Pharma's new specialist within your field of expertise. You will join a team of experienced and highly skilled scientists committed to understand the mechanisms behind skin diseases and how our candidate drugs influence these mechanisms. We have just launched an extremely ambitious 2025 strategy and Clinical Pharmacology is an important part of that strategy. As specialist in population pharmacokinetics and quantitative pharmacology you will be a key driver on this journey. You can look forward to joining LEO in one of the most exciting times in our history. Your job You will join an international market leader within dermatology with focus on inflammatory skin diseases. We have a rich project portfolio that covers topical, systemic and mAb treatment solutions. Your overall focus will be to further build and implement population pharmacokinetics and PK/PD modelling in all of our clinical projects. Your primary tasks will be to: *Apply population PK & PK/PD modelling and simulation to support our clinical projects *Help optimize clinical trial protocols/conduct in particular clinical pharmacology studies *Deliver required documentation for authority submissions *Represent our discipline at authority and external KOL interactions A vital part of the job is also to keep yourself updated with new developments in the field of population pharmacokinetics and quantitative pharmacology, including relevant regulatory legislation, guidelines and submission principles. It is important to keep appraised with the literature and ensure continued learning. Your profile You have worked within the area of population pharmacokinetics and quantitative pharmacology. It is an advantage if you have experience from authority interactions and clinical trial design of typical clinical pharmacology studies, and if you have published in peer-reviewed. You must be able to communicate complex information to colleagues across the LEO organisation and to external stakeholders. You thrive on creating results via constructive collaboration. About the Clinical Pharmacology department You will join a well-functioning team of 6 colleagues. We are responsible for PK, PK/PD, clinical pharmacology trials, biomarker assessment and mode of action understanding of our drugs in all phases of clinical development. We are part of the Medical Science and Safety area, which is a multifunctional function that embraces several aspects regarding clinical studies, descriptive characterisation and biological understanding of the drug action in human beings. How to apply To learn more about this exciting opportunity, please visit http://www.leo-pharma.com/Home/Careers/Jobs.aspx. Look for the job advert and submit your application online. We look forward to receiving your application. About LEO Pharma LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 100 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 4,800 people worldwide. For more information, visit www.leo-pharma.com. This e-mail, inclusive of attachments, is intended for the person(s) stated above and may contain confidential information. Unauthorised reading, disclosure, copying, distribution or use of this information may violate rights to proprietary information. If you are not an intended recipient, please return this e-mail to the sender and delete your copy. Thank you.